News
Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...
The Trump administration is planning to pilot covering weight loss drugs. A longtime healthcare exec moves to a strategic advisory role at General Catalyst.
With approximately 60% of prescription drugs coming from Europe, including major brands like Ozempic, Botox and Eliquis, many ...
Health and Human Services Secretary Robert F. Kennedy Jr said that President Donald Trump calls him up “three or four times a week” to hound him with the same question. At such a critical moment in US ...
GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...
Legislative efforts and a Trump administration initiative could lead in the near future to Medicare beneficiary access to ...
10h
Money Talks News on MSNMedicare to Slash Prices on Ozempic, 14 Other Drugs — but Not Until 2027Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results